Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mermaid Bio GmbH logo — Pioneering Intercellular Antibodies

Mermaid Bio GmbH

Pioneering Intercellular Antibodies

Founded 2022 Germany Germany 4 employees Biopharma, Biotechnology

General Information

Company Name Mermaid Bio GmbH
Founded Year 2022
Location Germany Germany +2
Employees 4
Industries Biopharma, Biotechnology
Social

Get notified when Mermaid Bio GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mermaid Bio GmbH

Mermaid Bio is a biopharmaceutical startup pioneering intercellular antibodies. Founded in 2022 and headquartered in Germany, the company's mission is to discover and develop breakthrough intrabodies, focusing on antibodies for intracellular targets to address unmet patient needs. What sets Mermaid Bio apart is its unique approach that links single domain antibodies (nanobodies) with advancements in drug delivery, specifically utilizing mRNA/LNP systems. This proprietary platform has the potential to revolutionize medicine production. As of now, there is no public information available regarding Mermaid Bio's last investment or the involved investors. Despite the absence of recent investment details, the industry focus of the company in biopharma and biotechnology demonstrates its alignment with areas of substantial growth and innovation within the healthcare and life science sectors. With its pioneering technology and forward-thinking approach, Mermaid Bio has the potential to make a significant impact in the biopharmaceutical landscape, catering to unmet medical needs and advancing treatment options for patients.

Taxonomy: Intercellular Antibodies, Intrabodies, Nanobodies, mRNA, LNP Systems, Drug Delivery, R&D, Female Leaders, Leadership, Munich, Melbourne

No funding data available for Mermaid Bio GmbH yet.

Get notified when Mermaid Bio GmbH raises funding

Mermaid Bio GmbH Alternatives & Competitors

Mermaid Bio GmbH vs
Medicovestor, Inc.
Medicovestor, Inc. United States

Spearheading medical advances

Seed
6 employees
Biotechnology
Mermaid Bio GmbH vs
NovalGen
NovalGen United Kingdom

Breakthrough bispecific antibody therapies harnessing the immune system to fight cancer

15 employees
Mermaid Bio GmbH vs
DJS Antibodies
DJS Antibodies United Kingdom

Unlocking immunology to deliver revolutionary medicines

Seed
21 employees
Biotechnology, Health Care
Also compare with: Mermaid Bio GmbH vs Latent Labs Latent Labs

FAQ About Mermaid Bio GmbH

Pioneering Intercellular Antibodies
Mermaid Bio GmbH was founded in 2022.
Mermaid Bio GmbH is headquartered in Germany.
Mermaid Bio GmbH operates in the following industries: Biopharma, Biotechnology.
Mermaid Bio GmbH has approximately 4 employees.
Top alternatives and competitors to Mermaid Bio GmbH include Medicovestor, Inc., NovalGen, DJS Antibodies, Radiant Biotherapeutics, FairJourney Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mermaid Bio GmbH and Medicovestor, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mermaid Bio GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy